Expression of the p53 protein in sun-damaged skin

Acta Dermato-Venereologica

Volumn 76, Issue 3, 1996, Pages 203-204

  Barnadas, María A ^a   Colomo, Lluis ^a   Curell, Román ^a   De Moragas, José M ^a,b  

^a St Cross and St Paul Hospital   (Spain)

^b Hospital de la Sta Creu i St Pau ^*  (Spain)

Author keywords

mutation; photoaging

Indexed keywords

PROTEIN P53;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SKIN INJURY; SUNBURN;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MALE; MIDDLE AGED; SKIN; SKIN AGING; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030013907     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Yonish Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991; 352: 345-347.
2. Lane DP. p53, guardian of the genome. Nature 1992; 358: 15-16.
3. McNutt NS, Saenz-Santamaria C, Volkenandt M, Shea CR, Albino AP. Abnormalities of p53 protein expression in cutaneous disorders. Arch Dermatol 1994; 130: 225-232.
4. Campbell C, Quinn AG, Angus B, Reed JL. The relation between p53 mutation and p53 immunostaining in non-melanoma skin cancer. Br J Dermatol 1993; 129: 235-241.
5. Hall PA, McKee PH, Menage HP, Dover R, Lane DP. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 1993; 8: 203-207.
6. Campbell C, Quinn AG, Angus B, Farr PM, Rees JL. Wavelength specific patterns of p53 induction in human skin following exposure to UV radiation. Cancer Res 1993; 53: 2697-2699.
7. Maltzmann W, Czyzk L. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol 1984; 4: 1689-1694.
8. Healey E, Reynolds NJ, Smith MD, Campbell C, Farr PM, Rees JL. Dissociation of erythema and p53 protein expression in human skin following UVB irradiation, and induction of p53 protein and mRNA following applications of skin irritants. J Invest Dermatol 1994; 103: 493-499.